March 1: The FDA on Friday granted full approval of J&Js Rybrevant in combination with chemotherapy as a first-line treatment for patients with non-small cell lung cancer (NSCLC) EGFR exon 20 insertion mutations, the company announced
Yang Z, Li T, Cui Y, Li S, Cheng C, Shen B, Le W (2019b) Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinsons Disease: A Potential Disease Biomarker
In this study, a fluorescent-sensing platform based on thiol-disulfide exchange reactions is presented for GSH detection
Lincoln's cost advantage is significant
The margin between correct and incorrect is narrow, and errors don't announce themselves
The Alliance for Pharmacy Compounding, which says that millions of doses of semaglutide and tirzepatide have been prepared and dispensed by compounding pharmacies across the US over the last two years, questioned whether the FDA had considered the number of patients who would need to transition from compounded semaglutide to the FDA-approved brands before changing its status.
